SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001047469-19-003079
Filing Date
2019-05-14
Accepted
2019-05-14 07:55:39
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 a2238770zs-3.htm S-3 469830
2 EX-1.1 a2238770zex-1_1.htm EX-1.1 228403
3 EX-5.1 a2238770zex-5_1.htm EX-5.1 32006
4 EX-23.1 a2238770zex-23_1.htm EX-23.1 3008
5 G96112KGI001.GIF g96112kgi001.gif GRAPHIC 902
6 G96112KGI002.GIF g96112kgi002.gif GRAPHIC 961
7 G96112KGI003.GIF g96112kgi003.gif GRAPHIC 3617
  Complete submission text file 0001047469-19-003079.txt   742275
Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971
CATABASIS PHARMACEUTICALS INC (Filer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-231441 | Film No.: 19820459
SIC: 2834 Pharmaceutical Preparations